TSC22D2
TSC22 domain family protein 2
Also known as: KIAA0669, T22D2_HUMAN, TILZ4a, TILZ4b, TILZ4c
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75157
- Gene
- TSC22D2
- Ensembl
- ENSG00000196428
- Chromosome
- 3
- Canonical length
- 780 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Cytosol
OverviewNCBI Gene
Involved in negative regulation of cell cycle. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
780 residues, UniProt reviewed canonical sequence.
>O75157|TSC22D2
1 MSKMPAKKKS CFQITSVTTA QVATSITEDT ESLDDPDESR TEDVSSEIFD VSRATDYGPE
61 EVCERSSSEE TLNNVGDAET PGTVSPNLLL DGQLAAAAAA PANGGGVVSA RSVSGALAST
121 LAAAATSAPA PGAPGGPQLA GSSAGPVTAA PSQPPTTCSS RFRVIKLDHG SGEPYRRGRW
181 TCMEYYERDS DSSVLTRSGD CIRHSSTFDQ TAERDSGLGA TGGSVVVVVA SMQGAHGPES
241 GTDSSLTAVS QLPPSEKMSQ PTPAQPQSFS VGQPQPPPPP VGGAVAQSSA PLPPFPGAAT
301 GPQPMMAAAQ PSQPQGAGPG GQTLPPTNVT LAQPAMSLPP QPGPAVGAPA AQQPQQFAYP
361 QPQIPPGHLL PVQPSGQSEY LQQHVAGLQP PSPAQPSSTG AAASPATAAT LPVGTGQNAS
421 SVGAQLMGAS SQPSEAMAPR TGPAQGGQVA PCQPTGVPPA TVGGVVQPCL GPAGAGQPQS
481 VPPPQMGGSG PLSAVPGGPH AVVPGVPNVP AAVPAPSVPS VSTTSVTMPN VPAPLAQSQQ
541 LSSHTPVSRS SSIIQHVGLP LAPGTHSAPT SLPQSDLSQF QTQTQPLVGQ VDDTRRKSEP
601 LPQPPLSLIA ENKPVVKPPV ADSLANPLQL TPMNSLATSV FSIAIPVDGD EDRNPSTAFY
661 QAFHLNTLKE SKSLWDSASG GGVVAIDNKI EQAMDLVKSH LMYAVREEVE VLKEQIKELV
721 ERNSLLEREN ALLKSLSSND QLSQLPTQQA NPGSTSQQQA VIAQPPQPTQ PPQQPNVSSALocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSC22D2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.71
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 33 nTPM
- liver: 28 nTPM
- smooth muscle: 25 nTPM
- endometrium: 22 nTPM
- gallbladder: 21 nTPM
- esophagus: 20 nTPM
Single-cell type
- ocular epithelial cells: 932 nCPM
- distal convoluted tubule cells: 907 nCPM
- urothelial cells: 654 nCPM
- esophageal apical cells: 510 nCPM
- neutrophils: 479 nCPM
- smooth muscle cells: 441 nCPM
Immune cell
- non-classical monocyte: 2.9 nTPM
- neutrophil: 2.2 nTPM
- eosinophil: 2 nTPM
- NK-cell: 2 nTPM
- MAIT T-cell: 1.8 nTPM
- classical monocyte: 1.7 nTPM
Brain region
- cerebral cortex: 42 nTPM
- white matter: 36 nTPM
- cerebellum: 35 nTPM
- pons: 34 nTPM
- midbrain: 34 nTPM
- medulla oblongata: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 0.7
- DepMap mean gene effect
- -0.41
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Protein domainsUniProt · Pfam · InterPro
- TSC22/Bun
- TSC22/Bun, conserved site
- TSC-22/dip/bun family
- TSC22 domain-containing protein 2
InteractionsUniProt · HPA
Protein binding partners of TSC22D2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSC22D2 as an antibody target. Whether an autoantibody or antibody against TSC22D2 could matter depends on whether native TSC22D2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSC22D2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TSC22D2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...